RLBEX
Price
$34.79
Change
-$0.05 (-0.14%)
Updated
May 23 closing price
Net Assets
237.69B
SVBCX
Price
$28.63
Change
-$0.08 (-0.28%)
Updated
May 23 closing price
Net Assets
5.62B
Interact to see
Advertisement

RLBEX vs SVBCX

Header iconRLBEX vs SVBCX Comparison
Open Charts RLBEX vs SVBCXBanner chart's image
American Funds American Balanced R4
Price$34.79
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets237.69B
JHancock Balanced C
Price$28.63
Change-$0.08 (-0.28%)
VolumeN/A
Net Assets5.62B
RLBEX vs SVBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBEX vs. SVBCX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBEX is a Buy and SVBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 238B vs. SVBCX (5.62B). RLBEX pays higher dividends than SVBCX: RLBEX (1.98) vs SVBCX (0.92). RLBEX was incepted earlier than SVBCX: RLBEX (23 years) vs SVBCX (26 years). SVBCX (1.74) is less costly to investors than RLBEX (0.59). SVBCX is a more actively managed with annual turnover of: 67.00 vs. RLBEX (44.00). RLBEX has a lower initial minimum investment than SVBCX: RLBEX (250) vs SVBCX (1000). RLBEX annual gain was more profitable for investors over the last year : 4.75 vs. SVBCX (2.81). SVBCX return over 5 years is better than : 41.64 vs. RLBEX (38.04).
RLBEXSVBCXRLBEX / SVBCX
Total Expense Ratio0.591.7334%
Annual Report Gross Expense Ratio0.591.7434%
Fund Existence23 years26 years-
Gain YTD1.9760.578342%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets238B5.62B4,236%
Annual Yield % from dividends1.980.92215%
Returns for 1 year4.752.81169%
Returns for 3 years22.5725.6988%
Returns for 5 years38.0441.6491%
Returns for 10 years54.3057.5394%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PENN14.660.46
+3.24%
PENN Entertainment
AHH6.82N/A
N/A
Armada Hoffler Properties
INDP0.38N/A
N/A
Indaptus Therapeutics
NBIX119.12-1.44
-1.19%
Neurocrine Biosciences
ZENV1.25-0.06
-4.58%
Zenvia